Cormorant Asset Management’s Veracyte VCYT Stock Holding History

Cormorant Asset Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-137,990	Closed	-$745K	–	90
2016 Q1	$745K	Hold	137,990	–	–	0.11%	73
2015 Q4	$994K	Hold	137,990	–	–	0.12%	69
2015 Q3	$647K	Hold	137,990	–	–	0.1%	81
2015 Q2	$1.54M	Buy	137,990 +2,800	+2%	+$27.6K	0.2%	65
2015 Q1	$984K	Buy	135,190 +34,990	+35%	+$287K	0.15%	62
2014 Q4	$968K	Buy	+100,200	New	+$782K	0.15%	63

Other funds holding VCYT

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cormorant Asset Management's VCYT Position: Q2 2016 in Review

Cormorant Asset Management sold out of Veracyte (VCYT) in Q2 2016, closing a stake of 137,990 shares — an estimated $745K sold.

Cormorant Asset Management first reported a position in VCYT in Q4 2014 and held it in 6 quarters. The position peaked at $1.54M in Q2 2015. 58 funds tracked by Wall St. Rank hold VCYT as of Q2 2016.

Cormorant Asset Management reported no remaining Veracyte position as of Q2 2016 after selling out during the quarter.
Cormorant Asset Management sold 137,990 Veracyte shares in Q2 2016, an estimated $745K.
Cormorant Asset Management first reported a position in Veracyte in Q4 2014 and held it in 6 quarters.
Cormorant Asset Management's Veracyte position peaked at $1.54M in Q2 2015.
58 funds tracked by Wall St. Rank held Veracyte as of Q2 2016.

Based on Cormorant Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.